R. Kokko

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono et al. · New England Journal of Medicine · 2006 · 1.4K citations

Medicine, Oncology, Pharmacology +16

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Petri Bono, Vesa Kataja et al. · Journal of Clinical Oncology · 2009 · 459 citations · Full text

Medicine, Oncology, Pharmacology +17

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen et al. · Journal of Clinical Oncology · 2011 · 118 citations · Full text

Medicine, Oncology, Pharmacology +17

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

Irma Saarenmaa, Tiina Salminen, U. Geiger et al. · Breast Cancer Research and Treatment · 2001 · 116 citations

Medicine, Oncology, Radiology +12

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen et al. · JAMA Oncology · 2017 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17